JFW, NS, YZ, BC, and TWFY declare no conflicts of interest. AD reports clinical trial funding to institution - Abbvie, Alexion, Prothena, Janssen, Novartis, and Regeneron; IRC, DMC, or Steering Committee role with Abbvie, BMS, Janssen, and Prothena; Advisory Board role with Abbvie, BMS, Janssen, Prothena, and Pfizer.

Approval was granted by the Institutional Review Board of the Medical College of Wisconsin and the Wisconsin Division of Public Health Data Governance Board. All methods were performed in accordance with the relevant guidelines and regulations. A limited data set was utilized from the WI Cancer Reporting System where the only HIPAA identifiers utilized are dates or certain allowable geographic subdivisions. Thus, informed consent was not applicable for this study.